These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 21546955)

  • 1. Companies race to develop first Hedgehog inhibitor cancer drug.
    Dolgin E
    Nat Med; 2011 May; 17(5):523. PubMed ID: 21546955
    [No Abstract]   [Full Text] [Related]  

  • 2. Hedgehog pathway inhibition and the race against tumor evolution.
    Atwood SX; Chang AL; Oro AE
    J Cell Biol; 2012 Oct; 199(2):193-7. PubMed ID: 23071148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sheep, lilies and human genetics.
    Bale AE
    Nature; 2000 Aug; 406(6799):944-5. PubMed ID: 10984033
    [No Abstract]   [Full Text] [Related]  

  • 4. Hedgehog- and mTOR-targeted therapies for advanced basal cell carcinomas.
    Piérard-Franchimont C; Hermanns-Lê T; Paquet P; Herfs M; Delvenne P; Piérard GE
    Future Oncol; 2015 Nov; 11(22):2997-3002. PubMed ID: 26437034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Targeted therapy of basal cell carcinoma through inhibition of the hedgehog signaling pathway].
    Hafner C
    Hautarzt; 2010 Apr; 61(4):356-8. PubMed ID: 20309511
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclopamine as a potential therapeutic agent for treatment of tumors related to hedgehog pathway mutations.
    Miller SJ; Yu TC
    Dermatol Surg; 2002 Feb; 28(2):187. PubMed ID: 11860435
    [No Abstract]   [Full Text] [Related]  

  • 7. Advanced basal cell carcinoma of the skin: targeting the hedgehog pathway.
    Sekulic A; Mangold AR; Northfelt DW; LoRusso PM
    Curr Opin Oncol; 2013 May; 25(3):218-23. PubMed ID: 23493193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Following the hedgehog to new cancer therapies.
    Dlugosz AA; Talpaz M
    N Engl J Med; 2009 Sep; 361(12):1202-5. PubMed ID: 19726764
    [No Abstract]   [Full Text] [Related]  

  • 9. Hedgehog drugs begin to show results.
    Garber K
    J Natl Cancer Inst; 2008 May; 100(10):692-7. PubMed ID: 18477794
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibiting Hedgehog: An Update on Pharmacological Compounds and Targeting Strategies.
    Galperin I; Dempwolff L; Diederich WE; Lauth M
    J Med Chem; 2019 Sep; 62(18):8392-8411. PubMed ID: 30986059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sonic Hedgehog pathway inhibitors: from clinical trials to clinical practice.
    Yan BY; Hibler BP; Menge T; Dunn L; Ho AL; Rossi AM
    Br J Dermatol; 2019 May; 180(5):1260-1261. PubMed ID: 30693471
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification of a small molecule inhibitor of the hedgehog signaling pathway: effects on basal cell carcinoma-like lesions.
    Williams JA; Guicherit OM; Zaharian BI; Xu Y; Chai L; Wichterle H; Kon C; Gatchalian C; Porter JA; Rubin LL; Wang FY
    Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4616-21. PubMed ID: 12679522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From teratogens to potential therapeutics: natural inhibitors of the Hedgehog signaling network come of age.
    Hovhannisyan A; Matz M; Gebhardt R
    Planta Med; 2009 Oct; 75(13):1371-80. PubMed ID: 19639534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of cyclopamine using a biomimetic and diastereoselective approach.
    Giannis A; Heretsch P; Sarli V; Stössel A
    Angew Chem Int Ed Engl; 2009; 48(42):7911-4. PubMed ID: 19591183
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of Hedgehog pathway inhibitors in Basal cell carcinoma.
    Basset-Seguin N; Sharpe HJ; de Sauvage FJ
    Mol Cancer Ther; 2015 Mar; 14(3):633-41. PubMed ID: 25585509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of a potent and orally active hedgehog pathway antagonist (IPI-926).
    Tremblay MR; Lescarbeau A; Grogan MJ; Tan E; Lin G; Austad BC; Yu LC; Behnke ML; Nair SJ; Hagel M; White K; Conley J; Manna JD; Alvarez-Diez TM; Hoyt J; Woodward CN; Sydor JR; Pink M; MacDougall J; Campbell MJ; Cushing J; Ferguson J; Curtis MS; McGovern K; Read MA; Palombella VJ; Adams J; Castro AC
    J Med Chem; 2009 Jul; 52(14):4400-18. PubMed ID: 19522463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hedgehog Pathway Inhibition for the Treatment of Basal Cell Carcinoma.
    Gutzmer R; Solomon JA
    Target Oncol; 2019 Jun; 14(3):253-267. PubMed ID: 31243642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vismodegib.
    Dlugosz A; Agrawal S; Kirkpatrick P
    Nat Rev Drug Discov; 2012 Jun; 11(6):437-8. PubMed ID: 22653209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basal cell carcinomas: attack of the hedgehog.
    Epstein EH
    Nat Rev Cancer; 2008 Oct; 8(10):743-54. PubMed ID: 18813320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral hedgehog-pathway inhibitors for basal-cell carcinoma.
    Lear JT
    N Engl J Med; 2012 Jun; 366(23):2225-6. PubMed ID: 22670909
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.